Neurogene Inc. (NGNE)
NASDAQ: NGNE · IEX Real-Time Price · USD
42.26
+0.84 (2.03%)
At close: Jul 19, 2024, 4:00 PM
42.20
-0.06 (-0.14%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Neurogene Market Cap
Neurogene has a market cap or net worth of $548.55 million as of July 22, 2024. Its market cap has increased by 1,432.26% in one year.
Market Cap
548.55M
Enterprise Value
394.37M
1-Year Change
1,432.26%
Ranking
Category
Stock Price
$42.26
Market Cap Chart
Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $548.55M, an increase of 380.76%. That is a compound annual growth rate of 16.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 548.50M | 1,105.49% |
| Dec 29, 2023 | 45.50M | 109.68% |
| Dec 30, 2022 | 21.70M | -89.39% |
| Dec 31, 2021 | 204.50M | -65.38% |
| Dec 31, 2020 | 590.70M | 25.07% |
| Dec 31, 2019 | 472.30M | 829.72% |
| Dec 31, 2018 | 50.80M | -81.59% |
| Dec 29, 2017 | 275.90M | -28.65% |
| Dec 30, 2016 | 386.70M | 80.03% |
| Dec 31, 2015 | 214.80M | 167.83% |
| Dec 31, 2014 | 80.20M | -29.71% |
| Mar 7, 2014 | 114.10M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quanterix | 547.65M |
| OmniAb | 546.39M |
| Canopy Growth | 546.34M |
| Terns Pharmaceuticals | 543.94M |
| PepGen | 543.15M |
| Contineum Therapeutics | 536.59M |
| Mereo BioPharma Group | 535.13M |
| PureTech Health | 528.89M |